Join us to Run/Walk
to Honor the Heroes
of Childhood Cancer
September 28
Courage. Strength. Believe.
The Kevin Cordasco Foundation: Something Yellow is committed to raising awareness for the heroes of childhood cancer. This spans to the children and teens going through cancer, to the families, to the hospital and caregivers, to the researchers developing new treatments and cure. We empower everyone to get involved, make a statement, and make a difference for our heroes - by wearing Something Yellow.
New Patient & treatment Room Dedicatation
The Kevin Cordasco Foundation is proud to announce that we have dedicated the new Patient and Treatment Room at Children's Hospital. As fate would have it, the plaque was installed on the 13th of January, which happened to be Kevin's favorite number.
Your contributions and support have made this, and all of our very important program's possible.
Shaping the Future of Pediatric Cancer Research
We’re proud to share that the Kevin Cordasco Foundation has funded the USC/CHLA 2025 Summer Oncology Research Fellowship, supporting the next generation of cancer researchers.
On July 21st, Melodie and I had the privilege of attending presentations from two outstanding student researchers supported by this fellowship: Frances Lai of the New Jersey Medical School at Rutgers University and Linwei Li of the University of Texas Rio Grande Valley School of Medicine.
Frances and Linwei presented their summer research focused on Neuroblastoma—the same cancer that took our son’s life—making the moment especially meaningful for us and our foundation.
It was an honor to meet these bright young scientists, Dr. Anat Epstein and their dedicated mentors.
Meet Our Hero
Kevin was an inspirational young man who battled Neuroblastoma, a rare childhood cancer that afflicts less than 700 children annually for nearly 7 years. He was diagnosed with stage 4, high risk neuroblastoma at just 10 years old. During his journey he lived in and out of hospitals searching for a life saving treatment and was finally diagnosed refractory, non-responsive to traditional chemotherapies.